202 related articles for article (PubMed ID: 32733026)
1. Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis.
Sun S; Chen H; Sun L; Wang M; Wu X; Xiao ZJ
Cell Death Dis; 2020 Jul; 11(7):595. PubMed ID: 32733026
[TBL] [Abstract][Full Text] [Related]
2. p53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis.
Lv T; Wu X; Sun L; Hu Q; Wan Y; Wang L; Zhao Z; Tu X; Xiao ZJ
Cell Death Dis; 2017 Aug; 8(8):e2995. PubMed ID: 28796261
[TBL] [Abstract][Full Text] [Related]
3. Mutation R273H confers p53 a stimulating effect on the IGF-1R-AKT pathway via miR-30a suppression in breast cancer.
Guo F; Chen H; Chang J; Zhang L
Biomed Pharmacother; 2016 Mar; 78():335-341. PubMed ID: 26898459
[TBL] [Abstract][Full Text] [Related]
4. Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response.
Sangodkar J; Dhawan NS; Melville H; Singh VJ; Yuan E; Rana H; Izadmehr S; Farrington C; Mazhar S; Katz S; Albano T; Arnovitz P; Okrent R; Ohlmeyer M; Galsky M; Burstein D; Zhang D; Politi K; Difeo A; Narla G
J Clin Invest; 2012 Jul; 122(7):2637-51. PubMed ID: 22653055
[TBL] [Abstract][Full Text] [Related]
5. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
[TBL] [Abstract][Full Text] [Related]
6. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
Dong P; Xu Z; Jia N; Li D; Feng Y
Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).
Tan BS; Tiong KH; Choo HL; Chung FF; Hii LW; Tan SH; Yap IK; Pani S; Khor NT; Wong SF; Rosli R; Cheong SK; Leong CO
Cell Death Dis; 2015 Jul; 6(7):e1826. PubMed ID: 26181206
[TBL] [Abstract][Full Text] [Related]
10. p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1.
Lv T; Lv H; Fei J; Xie Y; Lian D; Hu J; Tang L; Shi X; Wang J; Zhang S; Li F; Jiang X; Yi Y
J Cancer; 2020; 11(23):6874-6882. PubMed ID: 33123278
[TBL] [Abstract][Full Text] [Related]
11. An N
Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
[TBL] [Abstract][Full Text] [Related]
12. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
13. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
[TBL] [Abstract][Full Text] [Related]
15. Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis.
Zhang B; Guo DD; Zheng JY; Wu YA
Eur J Cancer Prev; 2018 Jan; 27(1):20-26. PubMed ID: 29084019
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
19. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression.
Wang W; Cheng B; Miao L; Mei Y; Wu M
Cell Death Dis; 2013 Apr; 4(4):e574. PubMed ID: 23559009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
